Company / Working Capital
Emergent BioSolutions Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$530.3M
FY2025
5-year range
-$18.5M / $898.3M
FY2021-FY2025
Trend
+21.5%
vs FY2024
Sector context
#84 of 213
Health Care
What the data says
At $530M, Emergent BioSolutions Inc.'s working capital ranks #84 of 213 in the Health Care sector. Working Capital has increased for 3 consecutive years, from -$19M in FY2022 to $530M in FY2025.
Based on SEC 10-K filings.
$530M in FY2025 with a 5-year CAGR of -8.2%.
Improved from $28M to $530M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -8.2%
- 10-Year CAGR
- -
Sector benchmark
#84 of 213 in Health CareTop 39% of 213This company $530.3M Sector average $934.6M
▼
-43.3% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s working capital has grown for 3 consecutive years.
- 5-year CAGR of -8.2%, indicating a declining trend.
- In FY2025, working capital increased 21.5% year-over-year.
- Ranks #84 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $530.3M | +21.5% |
| FY2024 | $436.3M | +1447.2% |
| FY2023 | $28.2M | +252.4% |
| FY2022 | -$18.5M | -102.1% |
| FY2021 | $898.3M | +10.7% |
| FY2020 | $811.4M | +72.7% |
| FY2019 | $469.9M | +11.8% |
| FY2018 | $420.4M | +9.1% |
| FY2017 | $385.3M | -4.7% |
| FY2016 | $404.4M | -7.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026